Last reviewed · How we verify
NCT05711953
Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief
NA trial testing Egyfil Pain Lotion in Pain in 26 participants. Completed in 20 July 2021.
20 July 2021
Quick facts
| Lead sponsor | Contrad Swiss SA |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 12 June 2021 |
| Primary completion | 20 July 2021 |
| Estimated completion | 20 July 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Egyfil Pain Lotion
Conditions studied
- Pain — all drugs for Pain →
- Muscle Rigidity — all drugs for Muscle Rigidity →
Sponsor
Contrad Swiss SA
Who can join
18 and older, any sex, with Pain or Muscle Rigidity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The application of a novel topical formulation for the treatment of muscular pain and stiffness (Egyfil), containing hyaluronic acid, SH-Polypeptide-6 and SH-Oligopeptide-1, is investigated to evaluate efficacy and safety in 26 patients with stiffness and pain. Single-Arm, Pre-Market, interventional study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A pre-market interventional, single-arm clinical investigation of a new topical lotion based on hyaluronic acid and peptides, EGYFIL<sup>TM</sup>, for the treatment of pain and stiffness in soft tissues.
Picotti S, Forte L, Serrentino J. · · 2023 · cited 2× · PMID 37784053 · DOI 10.1186/s12891-023-06903-y
Verify or expand the search:
- PubMed search for NCT05711953
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other Contrad Swiss SA trials
Trials by the same sponsor.
- NCT07322770 — Retrospective Evaluation of the Long-term Effectiveness of the CR500™ SINGLE-DOSE GEL Medical Device in Patients With Kn · completed
- NCT05886608 — Evaluation of the Effect of the AI500™ SINGLE-DOSE GEL Medical Device in Patients With Reduced Knee Function · NA · completed
- NCT05785520 — Evaluation of the "ST500 SINGLE- DOSE GEL" in Patients With Symptomatic Long Head of the Biceps Tendon Injury · NA · completed
- NCT05661162 — Evaluation of the Effect of the "CR500 SINGLE-DOSE GEL" Medical Device in Patients With Knee Osteoarthritis (KOA) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05711953 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Contrad Swiss SA
- Last refreshed: 20 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05711953.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing